Insiders Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Market Closed - Nasdaq Other stock markets 16:00:00 2024-06-28 EDT			5-day change	1st Jan Change
0.3385 ^USD	-6.08%		-8.51%	+23.99%

06-27	Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement	MT
06-26	Brainstorm Cell Therapeutics Inc. Reaches Alignment with Fda on Cmc Aspects of Phase 3B Nurown®? Clinical Trial	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Brainstorm Cell Therapeutics Announces Appointment of Haro Hartounian as EVP and COO	06-20	CI
Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024	04-16	CI
Brainstorm Cell Therapeutics Inc. Announces Management Changes	04-16	CI
Brainstorm Cell Therapeutics Inc. Announces Executive Changes	12-20	CI
Brainstorm Cell Therapeutics Inc. Announces Resignation of Dr. Kirk Taylor as EVP and Chief Medical Officer	23-10-24	CI
BrainStorm Cell Therapeutics Inc. Appoints Bob Dagher as Executive Vice President and Chief Development Officer	23-07-12	CI
Brainstorm Cell Therapeutics Appoints Nir Naor as Board Member and Audit Committee Chair	23-06-21	CI
Brainstorm Cell Therapeutics Chief Operating Officer David Setboun Resigns	23-05-25	MT
Brainstorm Cell Therapeutics Inc Announces Resignation of David Setboun as Executive Vice President and Chief Operating Officer	23-05-24	CI
Brainstorm Cell Therapeutics Inc. Announces Appointment of Kirk Taylor as Executive Vice President and Chief Medical Officer, Effective May 1, 2023	23-04-25	CI
BrainStorm Cell Therapeutics Announces Promotion of Dr. Stacy Lindborg to Co-Chief Executive Officer	23-01-04	CI
Brainstorm Cell Therapeutics Inc. Appoints Antal Pearl-Lendner as Chief Legal Counsel	22-05-12	CI
Brainstorm Cell Therapeutics Inc. Announces Retirement of Sankesh Abbhi as Board of Director	21-12-17	CI
Brainstorm Cell Therapeutics Expands Leadership Team to Support Clinical Development and Medical Affairs	21-11-08	CI
Brainstorm Cell Therapeutics Inc. Announces Board Changes	21-10-28	CI
Cidara Therapeutics : Appoints Preetam Shah Chief Financial Officer	21-09-01	MT
Brainstorm Cell Therapeutics Inc. Announces Executive Changes	21-08-25	CI
Brainstorm Cell Therapeutics Inc. Appoints William K. White as Senior Vice President, Head of Market Access & Pricing	20-09-29	CI
Brainstorm Cell Therapeutics Inc. Appoints Anthony Waclawski as Executive Vice President, Global Head of Regulatory Affairs	20-09-02	CI
Brainstorm Appoints Stacy R. Lindborg, as Executive Vice President, Head of Global Clinical Research	20-05-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Brainstorm Cell Therapeutics Inc.

Equities

BCLI

US10501E2019

Insiders

Filters